Angion Biomedica announced that on December 15, it received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market notifying Angion that for the last 30 consecutive business days the bid price of Angion’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq listing rule 5450.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ANGN:
